Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels ≤ 10 ng/mL

The objective of the current study was to develop a model for predicting the presence of prostate carcinoma using clinical, laboratory, and transrectal ultrasound (TRUS) data.

[1]  R. Babaian,et al.  Advances in the application of prostate-specific antigen in the detection of early-stage prostate cancer. , 1999, Seminars in oncology.

[2]  G Bartsch,et al.  Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer. , 2001, Urology.

[3]  P. Walsh.  A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. , 2003, The Journal of urology.

[4]  W. Ellis,et al.  Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. , 1994, The Journal of urology.

[5]  P Finne,et al.  Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network. , 2000, Urology.

[6]  J. Richie,et al.  Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. , 2000, Urology.

[7]  M. Terris,et al.  Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. , 1998, The Journal of urology.

[8]  D. Ornstein,et al.  A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. , 2000, The Journal of urology.

[9]  A. Partin,et al.  An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 cases. , 1998, Urology.

[10]  Z. Zhang,et al.  Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL. , 2000, Urology.

[11]  A S Whittemore,et al.  Prostate cancer incidence and mortality in the United States and the United Kingdom. , 1998, Journal of the National Cancer Institute.

[12]  A W Partin,et al.  Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. , 1998, JAMA.

[13]  M. Kattan,et al.  Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL. , 1999, Urology.

[14]  P C Prorok,et al.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. , 2000, Controlled clinical trials.

[15]  A. Partin,et al.  A neurocomputational model for prostate carcinoma detection , 2003, Cancer.

[16]  M. Kattan,et al.  A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. , 1998, Journal of the National Cancer Institute.

[17]  Charles E. Metz,et al.  Software for ROC Analysis , 2000 .

[18]  H. D. de Koning,et al.  Prostate cancer detection at low prostate specific antigen. , 2000, The Journal of urology.

[19]  P. Swindle,et al.  Nomograms and instruments for the initial prostate evaluation: the ability to estimate the likelihood of identifying prostate cancer. , 2002, Seminars in urologic oncology.

[20]  Mesut Remzi,et al.  Novel artificial neural network for early detection of prostate cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  K. Shinohara,et al.  The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. , 2000, The Journal of urology.

[22]  Klaus Jung,et al.  Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies. , 2002, Clinical chemistry.

[23]  Michael Kattan,et al.  Statistical prediction models, artificial neural networks, and the sophism "I am a patient, not a statistic". , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  H M Rosenberg,et al.  Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. , 2001, Journal of the National Cancer Institute.

[25]  W. Cooner,et al.  Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. , 1990, The Journal of urology.

[26]  Louis R Kavoussi,et al.  Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. , 1994, The Journal of urology.